National VTE Audit Day: Results and Feedback

www.saferhealthcarenow.ca

National VTE Audit – October 2014

RESULTS

Bill Geerts & Artemis Diamantouros

Virginia Flintoft, Anne MacLaurin and Alex Titeu CPSI Central Measurement Team

Nov. 2014

Did you Join the Call Correctly?

You Joined Correctly!

There IS a phone icon beside your name.

You Joined Incorrectly!

There is NO phone icon beside your name.

If you joined incorrectly and there is NO phone icon

beside your name, click the audio button on the right-

hand side of the screen, below the participant list

Please join the audio conference using a phone for better audio quality.

1. For direct lines, choose “Call me at a new number”

2. For lines with extension , choose “I will call in” and dial the

audio conference toll-free number found on the Session

Info tab, and when prompted, enter the access code and

attendee ID

Please use the chat to ask questions during the presentation, or raise hand when we pause for questions.

www.saferhealthcarenow.ca 4

1. Methodology

2. Audit participation

3. Appropriate thromboprophylaxis use

4. Types of thromboprophylaxis used

5. Reasons for not using appropriate

thromboprophylaxis

6. Use of Preprinted order sets

7. Feedback and discussion

VTE Audit Results - Outline

• National VTE Audit: October 1-15, 2014

• Audit Sample:

– General Internal Medicine and General Surgery

• National webinar (Sept. 8) - Call to Action

• Engagement of sites & registration

• Sites contacted by CMT:

– Identification of audit sample

– Creation of data collection forms

VTE Audit - Overview

• Launch of National VTE Audit:

• Data Collection: October 1 to 15

– Extension for data collection to October 31

– Data submission accepted up to November 7

• Error reports corrected and resubmitted by

Central Measurement Team (CMT)

• Data cleaning and Analyses conducted by CMT

with data from Patient Safety Metrics

(PS Metrics)

VTE Audit - Methodology

1. Methodology

thromboprophylaxis

Response Rate 2014 – Original and Cleaned

Originally

Submitted

Oct. 2014

Cleaned

Oct.2014

Sites 112 110

Patients 3,937 3,809

Overall Response Rate – 2013 v 2014

Sites 118 110

Patients 4,667 3,809

Responses by Province – 2013 v 2014

Responses by Major Patient Group –

2013 v 2014

2014 (n)=3,809

2013 (n)=4,667

1. Methodology

thromboprophylaxis

Receiving Appropriate TPX - Overall Rates

86% N=3,809

f pati

Appropriate TPX - By Major Patient Group

f pati

78% 86%

Receiving Appropriate TPX - by Province

f pati

Total (n)

National Average =86%

Receiving Appropriate TPX - by Province and Major Patient Group

f pati

Total (n)

Receiving Appropriate TPX - by Province and Region

Regions Reporting

National Average = 86%

f pati

Total (n)

1. Methodology

thromboprophylaxis

VTE Audit Day Results - Outline

Type of Thromboprophylaxis - Overall

• LMWH = dalteparin; enoxaparin; fondaparinux; nadroparin; tinzaparin

• Other = apixaban; dabigatran; rivaroxaban; warfarin (2013=6%; 2014=7%)

Year Patients

on TPX

LMWH LDH Mech

2013 3,619 61% 29% 4%

2014 2,601 60% 27% 6%

Type of Thromboprophylaxis - by Major Patient Group

Patient

Patients on

LMWH LDH Mech

Gen Med 1165 64% 24% 4%

Gen Surg 758 55% 33% 8%

Type of Thromboprophylaxis - by Province

Total (n)

Type of Thromboprophylaxis - by Province and Major Patient Group

Total (n)

1. Methodology

thromboprophylaxis

Reasons for not using TPX - Overall

Reasons for not using TPX - by Major Patient Group

1. Methodology

thromboprophylaxis

Preprinted Order Use –

Overall Rates – 2013 v 2014

N=3,809

f pati

Preprinted Order Use – By Major Patient Group

f pati

51% 46%

Preprinted Order Use – by Province

f pati

Total (n)

National Average =49%

Preprinted Orders – by Province and Major Patient Group

f pati

Total (n)

Appropriate Thromboprophylaxis and Preprinted Order Set Use

N=3,771 94%

Receiving Appropriate Thromboprophylaxis and Preprinted Order Sets – 2013 & 2014

Receiving Appropriate Thromboprophylaxis and Preprinted Order Sets by Service

N=3,202

• 2nd Canadian national VTE

thromboprophylaxis audit

• 110 centres and 3,809 patients

• Coast to coast representation (almost)

• Medical and surgical patients well

represented

Summary - Participation

• After data cleaning 8 fewer sites participated

this year representing 858 fewer patients

• Half as many patients from Ontario and 3

times as many from AB; no data from NL but 5

sites from QC vs 0 in 2013

• 25% - 35% fewer cases reported for Gen. Med

and Gen. Surg; 50% - 68% more cases in Med-

Surg and Other Surg in 2014

Summary – 2013 vs 2014 Audits

• No difference in proportional use of

Thrombolytics by type

• Slightly less use of Pre-printed Order Sets in

2014 (49% v 55%)

• Appropriateness of Thrombolytics was slightly

better in 2014

• Using Order Sets - 94% v 91%

• Not using Order Sets – 78% v 71%

Summary – 2013 vs 2014 Audits

Summary of 2014 Data

• Overall, thromboprophylaxis use = 86%

- Excellent response but still room for improvement

- 14% of patients at risk for VTE did not receive

appropriate thromboprophylaxis

• Variability in thromboprophylaxis use:

- By patient group:

– General Surgery 92%

– General Medicine 84%

- By province: 70% 96%

- By region across provinces: 55% 100%

Summary – Thromboprophylaxis Use

Summary – Types of Thromboprophylaxis

• Types of Thromboprophylaxis: • LMWH: 60%

• LDH: 26%

• LMWH + LDH: 87%

• Mechanical only: 5%

• Variability:

• By Patient Group:

• Medical: LMWH vs LDH (64% vs 24%)

• Surgical: LMWH vs LDH (56% and 33%)

• By province

• By region

• Overall: – 14% did not receive appropriate thromboprophylaxis

• Reasons:

• No thromboprophylaxis 73%

• Delay in start 8%

• Wrong dose 5%

• Modality varied from SHN recommendation 7%

Summary – Reasons for not using Recommended Thromboprophylaxis

• 49% of patients had admission / postop OS

• Huge differences by province (16% 69%) and

region

• Appropriate thromboprophylaxis more common

if OS used (94% vs 78%) – also in 2013

Summary – Order set use

• Territories not represented:

– NL, NWT, Yukon, Nunavut

• Some incomplete data submitted

• Potential participation bias:

– ?good centre bias

– ?good nursing unit bias

• Snap shot Audit

Summary - Limitations

1. Methodology

thromboprophylaxis

Thank you!

1. Questions

2. Comments/suggestions

and Learning

3. How can Safer

Healthcare Now! help

Thank You / Merci

Evaluation Poll

Sondage d’évaluation

Thank you / Merci

Central Measurement Team metrics@saferhealthcarenow.ca

Virginia Flintoft – 416-946-8350

Alexandru Titeu – 416-946-3103

National VTE Audit Day: Results and Feedback

Healthcare

Transcript of National VTE Audit Day: Results and Feedback

The Calgary Audit and Feedback Framework: a practical ...

Kathrina Lo - NSW Audit Office - Feedback on NSW 'Performance frameworks in custodial centre operations' Audit

Using the NIMC VTE Prophylaxis Section. Slide 2 of n Overview The burden of VTE in Australia The NIMC VTE Pilot How to use the NIMC VTE prophylaxis.

Drug Class Review: Target Specific Oral Anticoagulants ...€¦ · VTE prophylaxis in TKR VTE prophylaxis in THR Acute VTE treatment Extended VTE treatment ACS DVT Prophylaxis in

VTE Framework: Drafting

Vte prophylaxis

VTE RISK IN LOWER LIMB IMMOBILISATION + Clinical Audit... · VTE Risk in Lower Limb Immobilisation National Quality Improvement Project 2018/19 Page 4 Key recommendations 1. All EDs

Management of VTE

VTE VENOUS THROMBOEMBOLISM

VTE Framework: Carpentry

Vte presentation 190911

vte corporate profile

The Bigger Picture · The Bigger Picture Optimizing electronic audit and feedback through ... Audit and feedback intervention Aim to increase our understanding of how interventions

vte advsnced medicine.ppt

National VTE Audit Day Results

Vte presentation 2015

Electronic audit and feedback intervention with action ...

VTE-Filter presentation

Prevention of vte

VTE Thrombophilia Testing and Treatment€¦ · VTE –Thrombophilia Testing and Treatment Venkatesh Rudrapatna MD. Hypercoagulable States - VTE ... presence of persistent laboratory